J&J’s COVID Vaccine Contract With US Bucks Trend Of Increasingly Lucrative Deals

Estimated $14 price per dose for Janssen’s investigational vaccine is first drop in value since Operation Warp Speed started signing contracts. The $1bn purchase order for 100 million doses and earlier $456m for development work is considerably less lucrative than the $2.1bn deal with GSK/Sanofi announced last week, especially since Janssen’s product may end up being a one-dose regimen.

Blue Medical Disposable Face Mask with covid-19 printed on it. Covid-19 - Wuhan Novel Coronavirus pneumonia gets official name from WHO: COVID-19. Disposable breath filter face mask with earloop

The $1bn commitment from the US for 100 million doses of Johnson & Johnson’s coronavirus vaccine announced on 5 August is a hefty order – but only if you don’t compare it to the deal the government struck with GlaxoSmithKline plc and Sanofi the week before.

Under the agreement with the Janssen subsidiary, the US Health and Human Services Department and the Department of Defense will...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet